ROMERIO ALESSIO

Ruolo:
Assegnista di ricerca
Settore scientifico disciplinare:
Chimica organica (CHIM/06)

Pubblicazioni

  • Shirey, K., Romerio, A., Shaik, M., Leake, D., Palmer, C., Skupinska, N., et al. (2025). Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection. INNATE IMMUNITY, 31 [10.1177/17534259241313201]. Dettaglio

  • Sainz-Mejias, M., Ma, C., Hou, Y., Jurado-Martin, I., Romerio, A., Franco, A., et al. (2025). Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge. ACS INFECTIOUS DISEASES, 11(4), 894-904 [10.1021/acsinfecdis.4c00932]. Dettaglio

  • Franco, A., Aladailleh, Z., Romerio, A., Italia, A., Lami, F., Shaik, M., et al. (2025). Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists. RSC MEDICINAL CHEMISTRY, 16(5), 2261-2269 [10.1039/D4MD00950A]. Dettaglio

  • Ami, D., Franco, A., Artusa, V., Romerio, A., Shaik, M., Italia, A., et al. (2024). Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists. TALANTA, 275(1 August 2024) [10.1016/j.talanta.2024.126104]. Dettaglio

  • Lami, F., Romerio, A., Italia, A., Shaik, M., Martin-Santamaria, S., Peri, F. (2024). Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists. Intervento presentato a: SCI 2024, Elements for the future - 26-30 agosto, Milano, Italia. Dettaglio